On April 14, 2022, the FDA released draft guidance that aims to diversify the population of participants in clinical trials.…
Read More
In the not-so-distant past, IRBs reviewing artificial intelligence and machine learning (AI/ML) protocols were quick to give not-human subject research…
Read More
Have you ever heard the phrase "proper preparation prevents poor performance?" That refrain echoed in my mind as I enjoyed…
Read More
On Tuesday, February 15, Robert Califf, PhD, was confirmed by the US Senate to the position of commissioner of the…
Read More
This month's Research Ethics Roundup covers two major movements in the Biden administration's science personnel, a new and potentially problematic…
Read More